CNS · Cohen & Steers, Inc.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the transfer by the reporting person of shares of common stock to the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Shares held by the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Represents the transfer by the reporting person of shares of common stock to the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $77.16 to $77.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by the Daniel A. Noonan Revocable Trust, a revocable trust, of which Mr. Noonan and an immediate family member serve as trustees.

Represents the withholding by the issuer of shares of common stock in connection with the reporting person's tax obligations upon the vesting of previously reported restricted stock units ("RSUs") and delivery of the common stock underlying such RSUs.

Immediately following the delivery of the common stock underlying the RSUs described in footnote 1, the 3,465 shares of common stock so delivered were immediately transferred to the Daniel A. Noonan Revocable Trust. Such transfer was exempt from reporting under Rule 16a-13.

Represents restricted stock units ("RSUs") granted by the issuer to the reporting person. Any dividends paid on the issuer's common stock are paid in additional RSUs (the "dividend RSUs"). The RSUs vest ratably over four years, and the dividend RSUs vest on the fourth anniversary of the grant date of the RSUs.

Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $71.75 to $71.85. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by the Jon Young Cheigh 2024 Revocable Trust, a revocable trust, of which Mr. Cheigh and an immediate family member serve as trustees.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in May 2023, January 2024, January 2025, October 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's second quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2024, January 2025 and January 2026.

Represents the transfer by the reporting person of shares of common stock to the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Shares held by the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Represents the transfer by the reporting person of shares of common stock to the Edmond Dennis Villani Revocable Trust, a revocable trust, of which Dr. Villani and a member of his family serve as trustees.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in May 2023, January 2024, January 2025, October 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $65.50 to $65.90. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote.

Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $64.83 to $65.60. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote.